ADVB: Prakiraan gabungan firma investasi Advanced Biomed Inc

The market price of Advanced Biomed Inc (ADVB), as confirmed by the chart, reflects the dynamics of a company developing robotic systems for automated blood analysis to replace manual diagnostic labor. The current figure stands at 0.00, which correlates with a period of high capital expenditure amid weak profit inflows. Business development is further complicated by international logistics challenges for components from Asia and patent conflicts.

Advanced Biomed - Prakiraan konsensus analis ADVB (periode 07.03.2025 - 22.10.2026)

Rincian analitis perusahaan Advanced Biomed Inc (ADVB)

Indikator analitis utama advanbiomed.com (ADVB):

Rega saham advanbiomed.com|ADVB - Prakiraan konsensus analis|Kapitalisasi pasar Advanced Biomed Corp

Analisis fundamental perusahaan:Advanced Biomed Inc. (ADVB)

Produk asli Advanced Biomed Inc

For Advanced Biomed Inc (ADVB), whose diagnostic chip operations are constrained by strict reagent disposal regulations, the median target price reflects the professional consensus on the business's capitalization. This indicator aggregates the expectations of institutional players, enabling a timely detection of declining confidence in the issuer and helping to avoid prolonged losses during a systematic downward revision of the asset's fair value.

Perusahaan pesaing

Prakiraan konsensus analis beigene.com (ONC)|Prakiraan konsensus analis HALO (Halozyme)|RVMD: Prakiraan gabungan firma investasi|AAPG: Target konsensus|CGON: Bagan rega target|URGN: Prakiraan konsensus analis|BCAX (bicara.com) - Bagan rega target|PSNL (Personalis) - Prakiraan konsensus analis|Target konsensus Erasca Inc (ERAS)|Prakiraan konsensus analis DCTH|Prakiraan konsensus analis Y-mAbs Corp (YMAB)|Bagan rega target Aura Biosciences, Inc. AURA|CADL: Prakiraan gabungan firma investasi|Accuray - Prakiraan konsensus analis|SELLAS Life Sciences (SLS) - Target konsensus|ACTU: Prakiraan konsensus analis|Rata-rata rega prakiraan Citius Oncology Inc (CTOR)|Bagan rega target TuHURA Biosciences Inc.|TARA: Konsensus nilai wajar|Target konsensus FATE (Fate Therapeutics)|WHWK (aadibio.com) - Konsensus nilai wajar|Prakiraan konsensus analis TCRX (TScan Therapeutics, Inc.)|CSBR - Target konsensus|XBIT: Target konsensus|CVM - Prakiraan konsensus analis|OS Therapies (OSTX) - Bagan rega target|Radiopharm Theranostics Ltd - Konsensus nilai wajar|ARTV (Artiva Biotherapeutics Inc.) - Prakiraan konsensus analis|Rata-rata rega prakiraan Adlai Nortye Limited ANL|Prakiraan konsensus analis VERU|Prakiraan konsensus analis tempesttx.com (TPST)|Prakiraan konsensus analis XLO (Xilio Therapeutics)|RENB: Prakiraan gabungan firma investasi|MURA: Target konsensus|KAPA: Bagan rega target|OKUR: Prakiraan konsensus analis|CytoMed Therapeutics Limited (GDTC) - Prakiraan konsensus analis|Bagan rega target Curis Inc.|Prakiraan gabungan firma investasi APLM (Apollomics Corp)|Prakiraan konsensus analis THAR|Target konsensus Genprex Inc GNPX|Prakiraan konsensus analis CLDI (Calidi Biotherapeutics, Inc.)|Sunshine Biopharma Inc. (SBFM) - Rata-rata rega prakiraan|Xenetic Bio - Prakiraan konsensus analis|SLRX (Salarius Pharmaceuticals Inc) - Prakiraan gabungan firma investasi|PPBT (Purple Biotech Corp) - Target konsensus|American Oncology Network, Inc. - Konsensus nilai wajar|BGNE (BeiGene, Ltd.) - Prakiraan konsensus analis|Bagan rega target CKPT|Prakiraan konsensus analis ELEV|Target median analis icadmed.com|Bagan rega target Ikena Oncology IKNA|Notable Labs Corp (NTBL) - Rata-rata rega prakiraan|VIRX - Bagan rega target|morphosys.com (MOR) - Target konsensus|NAYA: Prakiraan konsensus analis|Rata-rata rega prakiraan Ascentage Pharma Group International (AAPGV)